MedPath

se of high definition transcranial direct current stimulation in negative symptoms of Schizophrenia and changes in proton magnetic resonance spectroscopic findings

Phase 3
Completed
Conditions
Health Condition 1: F203- Undifferentiated schizophrenia
Registration Number
CTRI/2019/05/018947
Lead Sponsor
Central institute of psychiatry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Diagnosis of Schizophrenia using Diagnostic Criteria for Research (DCR) of International Classification of Disease-10th edition (ICD-10, World Health Organization,1992)

2.Age between 18- 60 years of either sex

3.The Positive and Negative Syndrome Scale for Schizophrenia (PANSS) negative symptoms score of more than 15

4.Scale for Assessment of Negative Symptoms (SANS) score more than 20

5.Calgary Depression Scale for Schizophrenia (CDSS) score less than 7

6.Right handed

7.Patients giving written informed consent.

Exclusion Criteria

1.Presence of co-morbid neurological or other psychiatric disorder(s).

2.Patient with co morbid substance dependence, except nicotine and caffeine.

3.Having any metallic implants/parts in body

4.Subjects who have received Electroconvulsive therapy in past 6 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome of the study is change in negative symptoms score as assessed at the end of 2 weeks of HDtDCS treatment with the specially designed score sheet.Timepoint: PANSS, SANS, CGI, CDSS WILL BE APPLIED AT THE END OF 2 WEEKS & 6WEEKS
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes are changes in the levels of GABA, Glutamate, Glutamine, N-Acetyl Aspartate & N-Acetyl Aspartyl Glutamate in Dorsolateral Prefrontal Cortex using Proton MR Spectroscopic imaging and overall severity scores on CGI.Timepoint: Proton Magnetic Resonance Spectroscopy will be done before giving HD tDCS and after 2 sessions of HD tDCS and at the end of 2 weeks.
© Copyright 2025. All Rights Reserved by MedPath